HtrA2-mediated RIP1 cleavage regulates neuronal inflammation and death
HtrA2介导的RIP1裂解调节神经元炎症和死亡
基本信息
- 批准号:9371476
- 负责人:
- 金额:$ 22.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectApoptosisApoptoticBIRC4 geneBasal Ganglia DiseasesBirthCASP8 geneCell DeathCell SurvivalCellsCellular StressCessation of lifeCharacteristicsChronic stressCleaved cellCorpus striatum structureDevelopmentDiseaseEpithelialEpithelial CellsEventExhibitsGoalsHTRA2 geneHematopoieticHomeostasisHumanIn VitroInflammationInflammatoryInterventionKnock-outKnockout MiceLeadLinkMediatingMissense MutationMolecularMusMutationNecrosisNerve DegenerationNeurodegenerative DisordersNeuronsOrganOxidative StressPancytopeniaParkinson DiseasePathologicPatientsPerinatalPhenotypePhosphotransferasesPlayPost-Translational RegulationPredispositionProcessProtease DomainProtein DephosphorylationProteinsRIPK1 geneRIPK3 geneRegulationSerine ProteaseSpleenStressTNF geneTestingTherapeuticTissuesUbiquitinationUp-Regulationbasebrain tissueexperimental studyhematopoietic tissuein vivoinsightknock-downknockout genemotor neuron degenerationmutantneuron lossnovel diagnosticsnovel therapeutic interventionoverexpressionpostnatalprotein functionpublic health relevanceresponse
项目摘要
5. Project Summary/Abstract
The goals of this proposal are to define the molecular mechanisms by which HtrA2-mediated cleavage of RIP1
regulates inflammation and cell death in striatal neurons in response to TNF and oxidative stress, and to
assess the pathological relevance of upstream and downstream effectors of RIP1 (i.e. TNF and RIP3) in the
onset and progression of basal ganglia disorder in HtrA2-mutant (Mnd2; motor neuron degeneration 2) mice.
TNF and oxidative stress are significant underlying factors for many neurodegenerative diseases, and
identification of the key molecular events that control neuronal response to TNF and oxidative stress are an
important and urgent task for the development of novel diagnostic approaches and therapeutic strategies. RIP1
is a dual-function (adaptor and kinase) protein that plays a key role in TNF- and oxidative stress-induced cell
survival, apoptosis and necroptosis. The ability of RIP1 to modulate cell survival is largely controlled by its K63-
linked ubiquitination and NF-B activation, and the prodeath function of it is dependent on its kinase activity. It is
known that RIP1 overexpression promotes both NF-B activation and cell death; however, the post-translational
regulation of RIP1 protein abundance under basal and chronic stress conditions is largely unknown. HtrA2 is a
serine protease and has been shown to promote cell death by degrading anti-apoptotic XIAP and cIAP1/2
proteins; however, gene knockout (KO) studies reveal that HtrA2 KO mice exhibit neurodegenerative disorder
characteristic of Parkinson’s disease (PD), and that HtrA2 KO cells display significantly increased susceptibility
to stress-induced apoptosis and necrosis. Notably, Mnd2 mice exhibit the same phenotype with HtrA2 KO mice,
and were found to carry a missense mutation in the protease domain of HtrA2 gene. Mutations in human HTRA2
gene have also been found in sporadic PD patients, suggesting that HtrA2 enzymatic activity is required for the
suppression of inflammation and neuronal death. However, the substrate(s) responsible for PD-like phenotype in
Mnd2 mice have not yet been identified. We found that RIP1 is cleaved by HtrA2 in hematopoietic and brain
tissues of wild-type (WT) but not of Mnd2 mice. Importantly, knockdown of RIP1 in Mnd2 and HtrA2 KO cells
significantly suppressed the susceptibility of these cells to cellular stresses. Given that RIP1 overexpression is
known to cause NF-B activation and cell death, we hypothesize that HtrA2-mediated cleavage of RIP1 limits its
proinflammatory and prodeath functions to maintain the homeostasis of organ/tissues that are sensitive to RIP1
protein abundance, and that altered regulation of this process under conditions of chronic stresses could lead to
RIP1-mediated inflammation and neurodegeneration. To test these hypotheses, we propose to carry out the
following specific aims: Aim-1. Define the mechanisms by which RIP1 triggers inflammation and neuronal death
in the striatum of Mnd2 mice; Aim-2. Assess the pathological relevance of TNF and RIP3 in the development of
PD-like disease in Mnd2 mice. Thus the completion of this project has the potential to guide the development of
novel approaches for the therapy of neurodegenerative disease through the intervention of RIP1 cleavage.
5. 项目总结/摘要
该提案的目标是确定 HtrA2 介导的 RIP1 裂解的分子机制
调节纹状体神经元响应 TNFα 和氧化应激的炎症和细胞死亡,并
评估 RIP1 上游和下游效应器(即 TNFα 和 RIP3)的病理相关性
HtrA2 突变(Mnd2;运动神经元变性 2)小鼠基底神经节疾病的发病和进展。
TNFα 和氧化应激是许多神经退行性疾病的重要潜在因素,并且
识别控制神经元对 TNFα 和氧化应激反应的关键分子事件是
开发新的诊断方法和治疗策略的重要而紧迫的任务。恢复IP1
是一种双功能(接头和激酶)蛋白,在 TNFα 和氧化应激诱导的细胞中发挥关键作用
存活、凋亡和坏死性凋亡。 RIP1 调节细胞存活的能力很大程度上受其 K63- 控制
泛素化与 NF-κB 激活相关,其促死亡功能依赖于其激酶活性。这是
已知 RIP1 过度表达会促进 NF-κB 激活和细胞死亡;然而,翻译后
在基础和慢性应激条件下 RIP1 蛋白丰度的调节在很大程度上是未知的。 HtrA2 是
丝氨酸蛋白酶,已被证明可通过降解抗凋亡 XIAP 和 cIAP1/2 来促进细胞死亡
蛋白质;然而,基因敲除 (KO) 研究表明 HtrA2 KO 小鼠表现出神经退行性疾病
帕金森病 (PD) 的特征,并且 HtrA2 KO 细胞表现出显着增加的易感性
应激诱导的细胞凋亡和坏死。值得注意的是,Mnd2 小鼠表现出与 HtrA2 KO 小鼠相同的表型,
并被发现在 HtrA2 基因的蛋白酶结构域中携带错义突变。人类 HTRA2 突变
在散发性 PD 患者中也发现了该基因,这表明 HtrA2 酶活性是
抑制炎症和神经元死亡。然而,负责 PD 样表型的底物
Mnd2 小鼠尚未被鉴定。我们发现RIP1在造血和脑中被HtrA2裂解
野生型 (WT) 的组织,但不是 Mnd2 小鼠的组织。重要的是,Mnd2 和 HtrA2 KO 细胞中 RIP1 的敲低
显着抑制这些细胞对细胞应激的敏感性。鉴于 RIP1 过度表达是
已知会导致 NF-κB 激活和细胞死亡,我们假设 HtrA2 介导的 RIP1 裂解限制了其
促炎和促死亡功能,维持对 RIP1 敏感的器官/组织的稳态
蛋白质丰度,以及在慢性应激条件下改变这一过程的调节可能导致
RIP1 介导的炎症和神经变性。为了检验这些假设,我们建议进行
以下具体目标:Aim-1。定义 RIP1 触发炎症和神经元死亡的机制
在 Mnd2 小鼠的纹状体中;目标2。评估 TNFα 和 RIP3 在疾病发展中的病理相关性
Mnd2 小鼠的 PD 样疾病。因此,该项目的完成有可能指导发展
通过干预 RIP1 裂解来治疗神经退行性疾病的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HASEM HABELHAH其他文献
HASEM HABELHAH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HASEM HABELHAH', 18)}}的其他基金
The roles of TRAF2 and RIP1 in breast cancer cell survival
TRAF2 和 RIP1 在乳腺癌细胞存活中的作用
- 批准号:
10363270 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
The roles of TRAF2 and RIP1 in breast cancer cell survival
TRAF2 和 RIP1 在乳腺癌细胞存活中的作用
- 批准号:
10619506 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
Therapeutic efficacies of neutrophil elastase and RIP1 inhibitors in acute lung injury
中性粒细胞弹性蛋白酶和RIP1抑制剂治疗急性肺损伤的疗效
- 批准号:
10311120 - 财政年份:2020
- 资助金额:
$ 22.88万 - 项目类别:
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation
Caspase-8 裂解 RIP1 对于 TRAIL 诱导的 NF-kB 激活至关重要
- 批准号:
8033152 - 财政年份:2010
- 资助金额:
$ 22.88万 - 项目类别:
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation
Caspase-8 对 RIP1 的切割对于 TRAIL 诱导的 NF-kB 激活至关重要
- 批准号:
8403529 - 财政年份:2010
- 资助金额:
$ 22.88万 - 项目类别:
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation
Caspase-8 裂解 RIP1 对于 TRAIL 诱导的 NF-kB 激活至关重要
- 批准号:
7887290 - 财政年份:2010
- 资助金额:
$ 22.88万 - 项目类别:
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation
Caspase-8 裂解 RIP1 对于 TRAIL 诱导的 NF-kB 激活至关重要
- 批准号:
8206767 - 财政年份:2010
- 资助金额:
$ 22.88万 - 项目类别:
Regulation of TRAF2 Activity in Normal and Tumor Cells
正常细胞和肿瘤细胞中 TRAF2 活性的调节
- 批准号:
7339874 - 财政年份:2006
- 资助金额:
$ 22.88万 - 项目类别:
Regulation of TRAF2 Activity in Normal and Tumor Cells
正常细胞和肿瘤细胞中 TRAF2 活性的调节
- 批准号:
7187428 - 财政年份:2006
- 资助金额:
$ 22.88万 - 项目类别:
Regulation of TRAF2 Activity in Normal and Tumor Cells
正常细胞和肿瘤细胞中 TRAF2 活性的调节
- 批准号:
7034445 - 财政年份:2006
- 资助金额:
$ 22.88万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 22.88万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 22.88万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 22.88万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 22.88万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 22.88万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 22.88万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 22.88万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 22.88万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 22.88万 - 项目类别:














{{item.name}}会员




